German Biotech Startup Eversyn Eyes Strategic Expansion Into South Korea’s Nutrition and Biopharma Markets
- German biotech startup Eversyn is expanding into South Korea, offering advanced cell-free bioproduction technologies for complex HMOs and glycosylated biocompounds, which are crucial for infant nutrition, functional foods, and biopharma applications. - …